Frequently Asked Questions
The market is segmented based on The was valued at USD 17.29 billion in 2023. The market size is projected to grow at a CAGR of 14.59 % and reach USD 51.41 billion by 2031.
.
The Global Genotyping Market size was valued at USD 17.29 USD Billion in 2023.
The Global Genotyping Market is projected to grow at a CAGR of 14.59% during the forecast period of 2024 to 2031.
The major players operating in the market include Illumina, Inc. (U.S.), F. Hoffmann-La Roche AG (Switzerland), Thermo Fisher Scientific, Inc. (U.S.), Qiagen N.V. (Germany), Fluidigm Corporation (U.S.), Bio-Rad Laboratories, Inc. (U.S.), Agilent Technologies, Inc. (U.S.), Oxford Nanopore Technologies, Ltd. (U.K.), Pacific Biosciences of California, Inc. (U.S.)., Genewiz, Inc. (U.S.), Genomic Health, Inc. (U.S.), Eurofins Scientific SE (Germany), BGI Group (China), Danaher Corporation (U.S.), Luminex Corporation (U.S.).
